Cart
sales@molnova.com
Valategrast
CAS No. 220847-86-9
Valategrast( —— )
Catalog No. M13520 CAS No. 220847-86-9
Valategrast is a potent, α4β1 (VLA-4) and α4β7 dual antagonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 284 | Get Quote |
|
| 50MG | 1341 | Get Quote |
|
| 100MG | 2196 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameValategrast
-
NoteResearch use only, not for human use.
-
Brief DescriptionValategrast is a potent, α4β1 (VLA-4) and α4β7 dual antagonist.
-
DescriptionValategrast is a potent, α4β1 (VLA-4) and α4β7 dual antagonist.Asthma Discontinued.
-
In VitroValategrast contains a common l-phenylalanine-N-aroyl motif where the carboxylic acid is responsible for binding to the metal ion in the metal-ion-dependent adhesion site (MIDAS).
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetIntegrin
-
RecptorIntegrin
-
Research AreaInflammation/Immunology
-
IndicationAsthma
Chemical Information
-
CAS Number220847-86-9
-
Formula Weight604.953
-
Molecular FormulaC30H32Cl3N3O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 170 mg/mL (281.01 mM)
-
SMILESCCN(CC)CCOC(=O)C(CC1=CC=C(C=C1)NC(=O)C2=C(C=CC=C2Cl)Cl)NC(=O)C3=C(C=CC=C3Cl)C
-
Chemical Name2-(diethylamino)ethyl (2S)-2-[(2-chloro-6-methylbenzoyl)amino]-3-[4-[(2,6-dichlorobenzoyl)amino]phenyl]propanoate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Sidduri A, et al. Bioorg Med Chem Lett. 2002 Sep 2;12(17):2479-82.
molnova catalog
related products
-
RO0270608
RO0270608, the active metabolite of R411, is an orally active dual α4β1/α4β7 integrin antagonist with anti-inflammatory properties, useful for studying allergic inflammatory responses.
-
Zaurategrast
A potent and selective, orally bioavailable α4 integrin (α4β1/VLA-4 and, to a lesser extent, α4β7 integrin) antagonist.
-
AJM300
AJM300 (AJM 300, AJM-300) is a novel potent, selective, oraaly available alpha 4 integrin antagonist fortreatment of active ulcerative colitis.
